Xperi Inc.
XPER NYSE Services-Prepackaged Software Financials FY2020โFY2025
Last close ยท Oct 23, 2026
$5.18
0.6%What Xperi Inc. does
No business description yet.
- Legal name
- Xperi Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Feb 26, 2026
- Accession ยท CIK
- 0001193125-26-076849
0001788999
Revenue and margins
Xperi Inc. had $448M of revenue in fiscal 2025, down 9.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$5.9M in fiscal 2025, โ1.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Xperi Inc. returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 1.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Xperi Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $121M | $160M | $142M | $131M | $96.8M |
| Debt incl. finance leases | โ | $50.0M | $50.0M | $77.7M | $27.7M |
| Debt / equity | โ | 0.1x | 0.1x | 0.2x | 0.1x |
| Interest coverage | โ | โ495.7x | โ43.2x | โ28.9x | โ14.7x |
| Current ratio | 2.3x | 2.2x | 1.9x | 1.6x | 2.4x |
| Quick ratio | 2.3x | 2.2x | 1.9x | 1.6x | 2.4x |
| Total assets | $1.2B | $737M | $674M | $668M | $616M |
| Total liabilities | $213M | $288M | $287M | $239M | $202M |
| Shareholders' equity | $1.0B | $463M | $404M | $429M | $414M |
| Net debt (โ = net cash) | โ | โ$110M | โ$92.1M | โ$52.9M | โ$69.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 4 | 2 / 7 | 4 / 8 | 1 / 8 | 3 / 8 |
| Accruals ratio | โ | โ12.4% | โ74.2% | โ19.4% | 6.2% | โ8.7% |
| Altman Z'' | โ | โ | โ6.48 | โ2.23 | โ1.91 | โ1.39 |
6 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $376M | $486M | $502M | $521M | $494M | $448M |
| Research and development | $163M | $195M | $216M | $223M | $191M | $135M |
| Operating income | โ$153M | โ$162M | โ$749M | โ$130M | โ$87.1M | โ$43.7M |
| Interest expense | โ | โ | $1.5M | $3.0M | $3.0M | $3.0M |
| Pretax income | โ$151M | โ$160M | โ$748M | โ$130M | $11.6M | โ$40.6M |
| Income tax | โ$9.7M | $18.8M | $13.6M | $10.0M | $12.4M | $15.7M |
| Net income | โ$138M | โ$176M | โ$757M | โ$137M | โ$14.0M | โ$56.3M |
| Net income to common | โ | โ$176M | โ$757M | โ$137M | โ$14.0M | โ$56.3M |
| Diluted EPS | โ$3.29 | โ$4.18 | โ$18.02 | โ$3.18 | โ$0.31 | โ$1.23 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B | 0.05B |
| Cash flow | ||||||
| Cash from operations | โ$23.8M | โ$23.5M | โ$28.4M | $0.1M | โ$55.3M | โ$0.5M |
| Capital expenditure | $6.6M | $8.9M | $13.1M | $6.8M | $5.0M | $5.4M |
| Free cash flow | โ$30.4M | โ$32.3M | โ$41.5M | โ$6.8M | โ$60.4M | โ$5.9M |
| Depreciation and amortization | $16.7M | $22.6M | $20.5M | $16.6M | $12.6M | $13.4M |
| Stock-based compensation | $19.2M | $33.5M | $45.3M | $69.5M | $60.5M | $40.7M |
| Share buybacks | โ | โ | โ | $0.0M | $20.0M | $0.0M |
| Dividends and buybacks | โ | โ | โ | $0.0M | $20.0M | $0.0M |
| Balance sheet | ||||||
| Cash and short-term investments | $85.6M | $121M | $160M | $142M | $131M | $96.8M |
| Total debt | โ | โ | $50.0M | $50.0M | $77.7M | $27.7M |
| Current assets | โ | $277M | $332M | $317M | $305M | $267M |
| Current liabilities | โ | $120M | $150M | $165M | $185M | $111M |
| Inventory | โ | $5.1M | $6.7M | โ | โ | โ |
| Property and equipment, net | โ | $57.5M | $47.8M | $41.6M | $44.5M | $51.9M |
| Goodwill | $532M | $537M | $0.0M | โ | โ | $0.0M |
| Intangible assets | โ | $271M | $264M | $207M | $164M | $129M |
| Total assets | โ | $1.2B | $737M | $674M | $668M | $616M |
| Total liabilities | โ | $213M | $288M | $287M | $239M | $202M |
| Preferred stock | โ | โ | โ | โ | $0.0M | $0.0M |
| Shareholders' equity | $1.1B | $1.0B | $463M | $404M | $429M | $414M |
| Margins | ||||||
| Operating margin | โ40.6% | โ33.3% | โ149.2% | โ24.9% | โ17.6% | โ9.8% |
| EBITDA margin | โ36.1% | โ28.6% | โ145.1% | โ21.7% | โ15.1% | โ6.8% |
| Net margin | โ36.8% | โ36.1% | โ150.8% | โ26.2% | โ2.8% | โ12.6% |
| FCF margin | โ8.1% | โ6.6% | โ8.3% | โ1.3% | โ12.2% | โ1.3% |
| Returns | ||||||
| Return on capital | โ | โ | โ167.6% | โ32.8% | โ15.0% | โ10.0% |
| Return on capital employed | โ | โ14.6% | โ127.7% | โ25.5% | โ18.1% | โ8.7% |
| Return on equity | โ12.8% | โ16.7% | โ101.8% | โ31.5% | โ3.4% | โ13.4% |
| Return on assets | โ | โ14.3% | โ77.1% | โ19.4% | โ2.1% | โ8.8% |
| Return on tangible equity | โ25.3% | โ80.7% | โ380.6% | โ69.2% | โ5.3% | โ19.8% |
| Growth | ||||||
| Revenue growth | โ | 29.3% | 3.2% | 3.8% | โ5.3% | โ9.2% |
| Share count change | โ | 0.0% | 0.0% | 2.3% | 4.8% | 1.8% |
| Financial health | ||||||
| Debt / equity | โ | โ | 0.1x | 0.1x | 0.2x | 0.1x |
| Interest coverage | โ | โ | โ495.7x | โ43.2x | โ28.9x | โ14.7x |
| Current ratio | โ | 2.3x | 2.2x | 1.9x | 1.6x | 2.4x |
| Quick ratio | โ | 2.3x | 2.2x | 1.9x | 1.6x | 2.4x |
| Capital allocation | ||||||
| Capex / revenue | 1.8% | 1.8% | 2.6% | 1.3% | 1.0% | 1.2% |
| Stock comp / revenue | 5.1% | 6.9% | 9.0% | 13.3% | 12.3% | 9.1% |
| Quality scores | ||||||
| Piotroski F-score | โ | โ | 2.0 | 4.0 | 1.0 | 3.0 |
| Altman Z'' | โ | โ | โ6.5 | โ2.2 | โ1.9 | โ1.4 |
| Accruals ratio | โ | โ12.4% | โ74.2% | โ19.4% | 6.2% | โ8.7% |
Source: SEC EDGAR XBRL filings (CIK 0001788999). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
